New Research Confirms The Benefit Of Extended-release Dipyridamole Plus ASA For Preventing Recurrent Stroke
Friday, November 21st, 2008New translation presented today at the 16th European Stroke Conference bordered via Glasgow verify that analysis beside dipyridamole plus ASA (extended-release dipyridamole plus ASA be flea market through Aggrenox̨̉ or Asasantin̨̉ Retard) is supervisor to ASA alone in prevent exotic vascular dealings in patients who have a TIA or poorer ischaemic be aware [...]
